THE RELATIONSHIP BETWEEN THE MORPHOFUNCTIONAL STATE OF PANCREATIC INSULAR APPARATUS AND ISLET FIBROSIS IN OLD RATS UNDER ALLOXAN-INDUCED DIABETES AND ALPHA-LIPOIC ACID CORRECTION
L.A. Sredneva¹, Ju.N. Kljueva², V.V. Emelianov², E.A. Mukhlynina¹, I.F. Gette¹, I.G. Danilova¹
DOI: 10.22138/2500-0918-2022-19-3-210-221
¹ Institute of Immunology and Physiology of the Ural Branch of the Russian Academy of Sciences, Yekaterinburg, Russian Federation;
² Ural Federal University named after the first President of Russia B. N. Yeltsin, Yekaterinburg, Russian Federation
Abstract. The scientific data on age-related changes in the insular apparatus of the pancreas are contradictory, including age-related insular fibrosis. There are some questions about the relationship between different pathomorphological changes in the insular apparatus and the possibility of their pharmacological correction with antioxidants, for example, alpha-lipoic acid, proved for treatment of diabetic cardiomyopathy and polyneuropathy. The aim of this study is to identify the relationship between the morphofunctional state of pancreatic insular apparatus and islet fibrosis in old rats with alloxan-induced diabetes and its correction using alpha-lipoic acid. Materials and methods. The experiment was conducted on 40 white male Wistar rats, which were divided into 4 groups: 1st — young intact animals 6 months old (n=10), 2nd — control group, old intact animals 18 months old (n=10), 3rd — old animals 18 months old with experimental diabetes (n=10), 4th — old animals 18 months old with experimental diabetes mellitus and administration of alpha-lipoic acid (n=10). Diabetes mellitus was designed with 3-times intraperitoneal injections of alloxan solution at a total dose of 170 µg/kg of animal weight. Alpha-lipoic acid was administered intramuscularly at a dose of 4 mg/100g of animal weight for 30 days. A morphological investigation of the pancreas was conducted, followed by immunohistochemical staining for insulin, as well as an assessment of the histotopographic localization of collagen. The obtained data were processed by mathematical statistics. Results. Decrease in the functionality of the pancreatic insular apparatus is due to a decrease in the number of beta-cells and an increase in fibrotic changes in it as a result of physiological aging, which was confirmed by an increase in the level of glucose in the blood plasma and a decrease in insulin expression in the islets. Alloxan diabetes exacerbated these changes. Administration of alpha-lipoic acid to aged animals with experimental diabetes contributed to an increase in the number of islets, their cellularity, the content of islet beta cells and their insulin-producing activity, a decrease in blood glucose levels and the severity of fibrotic changes in the islets. Conclusion. In this study, it was shown for the first time that the administration of alpha-lipoic acid, which has an antioxidant capacity, caused a decrease in islet fibrosis in old animals with diabetes due to an increase in insulinocytes in the islet and a decrease in glucose concentration. Thus, alpha-lipoic acid has not only antidiabetic, but also geroprotective and antifibrogenic effects in old rats with alloxan-induced diabetes.
Keywords: pancreas, beta-cells, alloxan diabetes, islet fibrosis, alpha-lipoic acid
There is no conflict of interest.
Contact details of the corresponding author:
Elena A. Mukhlynina
elena.mukhlynina@yandex.ru
Received 14.05.2021
For citation:
Sredneva L.A., Kljueva Ju.N., Emelianov V.V., Mukhlynina E.A., Gette I.F., Danilova I.G. The relationship between the morphofunctional state of pancreatic insular apparatus and islet fibrosis in old rats under alloxan-induced diabetes and alpha-lipoic acid correction. Vestn. Ural. Med. Akad. Nauki. = Journal of Ural Medical Academic Science. 2022, Vol. 19, no. 3, pp. 210–221. DOI: 10.22138/2500-0918-2022-19-3-210-221 (In Russ)
REFERENSES
1. International Diabetes Federation. IDF Diabetes Atlas. 9th ed. Belgium: International Diabetes Federation, 2019. https://www.diabetesatlas.org/upload/resources/material/20200302_133351_IDFATLAS9e-final-web.pdf
2. Kehm R, König J, Nowotny K., Jung T., Deubel S., Gohlke S. et al. Age-related oxidative changes in pancreatic islets are predominantly located in the vascular system. Redox Biol., 2018, Vol. 15, pp. 387-93. DOI:10.1016/j.redox.2017.12.015.
3. Drigo R.A., Erikson G., Tyagi S., Capitanio Ju., Lyon J., Spigelman A.F. et al. Aging of human endocrine pancreatic cell types is heterogeneous and sex-specific. BioRxiv, 2019, p. 729541. DOI: 10.1101/72954.1.
4. Saisho Y., Butler A.E., Manesso E., Elashoff D., Rizza R.A., Butler P.C. β-cell mass and turnover in humans: effects of obesity and aging. Diabetes Care. 2013, Vol. 36, no. 1, pp. 111-17. DOI: 10.2337/dc12-0421.
5. Tuleta I., Frangogiannis N.G. Diabetic fibrosis. Biochim. Biophys. Acta Mol. Basis. Dis. 2021, Vol. 1867, no. 4, pp. 166044. DOI: 10.1016/j.bbadis.2020.166044.
6. Zechner D., Knapp N., Bobrowski A., Radecke T., Genz B., Vollmar B. Diabetes increases pancreatic fibrosis during chronic inflammation. Exp. Biol. Med. (Maywood). 2014, Vol. 239, no. 6, pp. 670-76. DOI: 10.1177/1535370214527890.
7. Zhao H.L., Lai F.M., Tong P.C., Zhong D.R., Yang D., Tomlinson B. et al. Prevalence and Clinicopathological Characteristics of Islet Amyloid in Chinese Patients with Type 2 Diabetes. Diabetes. 2003, Vol. 52, no. 11, pp. 2759-66. DOI: 10.2337/diabetes.52.11.2759.
8. Hayden M.R. Islet amyloid and fibrosis in the cardiometabolic syndrome and type 2 diabetes mellitus J. Cardiometab. Syndr. 2007, Vol. 2, no. 1, pp. 70-5. DOI: 10.1111/j.1559-4564.2007.06159.x.
9. Ko S.H., Kwon H.S., Kim S.R., Moon S.D., Ahn Y.B., Song K.H. et al. Ramipril treatment suppresses islet fibrosis in Otsuka Long-Evans Tokushima fatty rats. Biochem. Biophys. Res. Commun. 2004, Vol. 316, no. 1, pp. 114-22. DOI: 10.1016/j.bbrc.2004.02.023.
10. Homo-Delarche F., Calderari S., Irminger J.C., Gangnerau M.N., Coulaud J., Rickenbach K. et al. Islet inflammation and fibrosis in a spontaneous model of type 2 diabetes, the GK rat. Diabetes. 2006, Vol. 55, no. 6, pp. 1625-33. DOI: 10.2337/db05-1526.
11. Lee E., Ryu G.R., Ko S., Ahn Y., Song K. A role of pancreatic stellate cells in islet fibrosis and β-cell dysfunction in type 2 diabetes mellitus. Biochem. Biophys. Res. Commun. 2017, Vol. 485, no. 2, pp. 328-34. DOI: 10.1016/j.bbrc.2017.02.082.
12. Mozhejko L. A. Pancreatic stellate cells: structure and function. Part 1. Morphofunctional characteristics of pancreatic stellate cells in physiological conditions. Hepatology and gastroenterology. 2018, Vol. 2, no. 1, pp. 21-5. http://hepatogastro.grsmu.by/index.php/journalHandG/article/view/58 (in Russ)
13. Tutel’jan V.A., Mahova A.A., Pogozheva A.V., Shih E.V., Elizarova E.V., Hotimchenko S.A. Lipoic acid: physiological role and prospects for clinical use. Problems of nutrition. 2019, Vol. 88, no. 4, pp. 6-11. DOI: 10.24411/0042-8833-2019-10035. (in Russ)
14. Emelianov V.V., Leontev D.V., Ishchenko A.V., Bulavintseva T.S., Savateeva E.A., Danilova I.G. Atomic-force microscopy of erythrocytes and metabolic disorders in experimental diabetes mellitus and during the correction of diabetes with lipoic acid. Biophysics. 2016, Vol. 61, no. 6, pp. 906-10. DOI: 10.1134/S0006350916050067.
15. Tartea G.C., Florescu D.R., Mihailovici A.R., Donoiu I., Istrătoaie O. Alpha-lipoic acid and vitamin B complex slow down the changes in mice diabetic cardiomyopathy. Rom. J. Morphol. Embryol. 2020, Vol. 61, no. 2, pp. 521-28. DOI: 10.47162/RJME.61.2.22.
16. Danilova I.G., Gette I.F., Bulavintseva T.S. Method for simulating alloxan diabetes. Patent RF, № 2534411, 2014. https://yandex.ru/patents/doc/RU2534411C1_20141127 (in Russ)
17. Hewitt S.M., Baskin D.G., Frevert C.W., Stahl W.L, Rosa-Molinar E. Controls for immunohistochemistry: the Histochemical Society’s standards of practice for validation of immunohistochemical assays. J Histochem. Cytochem. 2014, Vol. 62, no. 10, pp. 693-97. DOI: 10.1369/0022155414545224.
18. Matsuda Y. Age-related pathological changes in the pancreastle. Front. Biosci. (Elite Ed.). 2018, Vol. 10, pp. 137-42. DOI: 10.2741/e813.
19. Lee E., Ryu G.R., Ko S.H., Ahn Y.B., Yoon K.H., Ha H. et al. Antioxidant treatment may protect pancreatic beta cells through the attenuation of islet fibrosis in an animal model of type 2 diabetes. Biochem. Biophys. Res. Commun. 2011, Vol. 414, no. 2, pp. 397-402. DOI: 10.1016/j.bbrc.2011.09.087.
Authors
Lyubov A. Sredneva
Institute of Immunology and Physiology of the Ural Branch of the Russian Academy of Sciences
Junior Researcher of the Laboratory of Morphology and Biochemistry
106, Pervomaiskaya Str., Yekaterinburg, 620049, Russian Federation
lyubabio44@gmail.com
Yulia N. Klyueva
Ural Federal University named after the first President of Russia B. N. Yeltsin
Senior lecturer at the Department of Medical Biochemistry and Biophysics
19, Mira Str., Yekaterinburg, 620002, Russian Federation
klueva.iulia@urfu.ru
Victor V. Emelianov
Ural Federal University named after the first President of Russia B. N. Yeltsin
Cand. Sci. (Med.), Associate Professor, Associate professor of the Department of Medical Biochemistry and Biophysics
19, Mira Str., Yekaterinburg, 620002, Russian Federation
evvd@list.ru
Elena A. Mukhlynina
Institute of Immunology and Physiology of the Ural Branch of the Russian Academy of Sciences
Cand. Sci. (Biol.), Senior Researcher of the Laboratory of Morphology and Biochemistry
106, Pervomaiskaya Str., Yekaterinburg, 620049, Russian Federation
elena.mukhlynina@yandex.ru
Irina F. Gette
Institute of Immunology and Physiology of the Ural Branch of the Russian Academy of Sciences
Cand. Sci. (Biol.), Senior Researcher of the Laboratory of Morphology and Biochemistry
106, Pervomaiskaya Str., Yekaterinburg, 620049, Russian Federation
i.goette@yandex.ru
Irina G. Danilova
Institute of Immunology and Physiology of the Ural Branch of the Russian Academy of Sciences
Dr. Sci. (Biol.), Associate Professor, Head of the Laboratory of Morphology and Biochemistry
106, Pervomaiskaya Str., Yekaterinburg, 620049, Russian Federation
ig-danilova@yandex.ru
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)
